Medialization Thryroplasty with a Customized Silicone Implant: Clinical Experience

The authors implemented medialization thyroplasty with a customized silicone implant in a total of 43 operations (36 patients) in 1999-2003. In 5 of these patients, the medialization thyroplasty was combined with cricothyroid subluxation (3 cases) or adduction of arytenoid cartilage (3 cases). One p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Folia phoniatrica et logopaedica 2008-03, Vol.60 (2), p.91-96
Hauptverfasser: Chrobok, V, Pellant, A, Sram, F, Fric, M, Praisler, J, Prymula, R, Svec, J G
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The authors implemented medialization thyroplasty with a customized silicone implant in a total of 43 operations (36 patients) in 1999-2003. In 5 of these patients, the medialization thyroplasty was combined with cricothyroid subluxation (3 cases) or adduction of arytenoid cartilage (3 cases). One patient received medialization thyroplasty, cricothyroid subluxation & adduction of arytenoid cartilage. Postoperatively 36 patients reported substantial reduction of their complaints, 5 patients found their voice improved & only 2 patients (5.6%) stated that their voice had not changed. The subjective evaluation was consistent with the findings of laryngoscopy & the preoperative & postoperative phonation parameters (maximum phonation time, maximum sound pressure level, jitter & shimmer). Average maximum phonation time was 6.5 s before surgery & 12.5 s after surgery. Maximum vocal sound pressure level was, on average, about 4 dB higher after surgery. Jitter was reduced from 5.3 to 3.7% & shimmer from 32.3 to 18.6%. The differences between presurgical & postsurgical parameters in our study were all statistically significant, indicating voice improvement. Medialization thyroplasty with a silicone implant was proven to be a successful & safe surgical method for the treatment of vocal fold paralysis. Adapted from the source document
ISSN:1021-7762